Novo Nordisk's latest salvo against Hims & Hers—a patent-infringement lawsuit—shows the fierce maneuvering over the booming obesity-drug market

The Danish drugmaker's patent lawsuit is the company's latest effort to shore up its place in the booming weight-loss drug market. ...